Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Show Display Options
Rank Status Study
1 Completed Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone
Conditions: Pharmacokinetics of Isavuconazole;   Pharmacokinetics of Ethinyl Estradiol and Norethindrone;   Healthy Volunteers
Interventions: Drug: isavuconazole;   Drug: Oral Contraceptive (ethinyl estradiol / norethindrone)
2 Completed A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
Condition: Healthy
Interventions: Drug: Ethinylestradiol;   Drug: Norethindrone;   Drug: JNJ-63623872
3 Completed
Has Results
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Condition: Bioequivalence
Interventions: Drug: Norethindrone/Ethinyl Estradiol;   Drug: Ovcon® 35 Fe
4 Completed
Has Results
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Condition: Healthy
Interventions: Drug: Norethindrone/Ethinyl Estradiol;   Drug: FEMCON® Fe
5 Completed Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
Condition: Hepatitis C
Interventions: Drug: FDC of Daclatasvir, Asunaprevir and BMS-791325;   Drug: FDC of Norethindrone and Ethinyl Estradiol;   Drug: BMS-791325
6 Completed TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Conditions: HIV;   AIDS;   Oral Contraceptive
Intervention: Drug: TMC278
7 Completed A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen
Condition: Hepatitis C Virus
Interventions: Drug: TMC435;   Drug: Ovysmen
8 Completed
Has Results
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
Condition: Healthy
Intervention: Drug: NPC-01
9 Completed
Has Results
Study of Safety and Efficacy of an Oral Contraceptive
Condition: Prevention of Pregnancy
Interventions: Drug: Norethindrone Acetate/Ethinyl Estradiol 24 Days;   Drug: Norethindrone Acetate /Ethinyl Estradiol 21 Days
10 Terminated Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
Condition: Healthy
Interventions: Drug: Tipranavir low dose;   Drug: Tipranavir high dose;   Drug: Ritonavir low dose;   Drug: Ritonavir high dose;   Drug: Norethindrone-Ethinyl Estradiol
11 Unknown  Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
Conditions: Postpartum Depressive Mood;   Postpartum Sexual Function
Interventions: Drug: Ethinyl Estradiol 35mcg/Norethindrone 1mg;   Drug: Ethinyl Estradiol 20mcg/Norethindrone 1mg
12 Completed Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: EE/NET
13 Completed
Has Results
Study of Safety and Efficacy of an Oral Contraceptive
Condition: Contraception
Intervention: Drug: Norethindrone/ethinyl estradiol
14 Completed
Has Results
A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
Condition: Pharmacokinetics
Interventions: Drug: Norethindrone/Ethinyl Estradiol;   Drug: Colchicine;   Drug: Placebo (for Colchicine)
15 Completed Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Condition: Pharmacokinetics
Interventions: Drug: Microgynon;   Drug: Noristerat(BAY86-6308)
16 Withdrawn A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Condition: Cancer
Interventions: Drug: Trametinib 0.5 mg;   Drug: Trametinib 2 mg;   Drug: ORTHO-NOVUM® tablet 1/35;   Drug: Placebo
17 Completed The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects
Condition: Arthritis
Interventions: Drug: OC containing EE and NET;   Drug: BMS-986142
18 Completed
Has Results
Study of Safety and Efficacy of an Oral Contraceptive
Condition: Contraception
Intervention: Drug: Norethindrone acetate/ethinyl estradiol
19 Completed
Has Results
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Condition: Healthy
Interventions: Drug: NPC-01;   Drug: IKH-01
20 Withdrawn A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Condition: Infections, Bacterial
Interventions: Drug: GSK1322322;   Drug: EE/NE;   Drug: GSK1322322 Placebo;   Drug: EE/NE Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.